Doctors' Health Fund

  eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Looking Foward

Medicare: options for the next 25 years

Richard B Scotton.

MJA 2000; 173: 41-43

The best long-term option for healthcare in Australia would be a system of managed competition

Make a comment - Register to be notified of new articles by e-mail - Current contents list - More articles on Administration and health services


While it is difficult to predict the evolution of healthcare over as long a period as 25 years, we can be reasonably sure that some of the trends of the past 25 years will continue, and possibly accelerate. Thus, medical knowledge and the technology and techniques for its application will continue to advance and, on balance, this will increase costs.

Two consequences will be that:

  • equitable access, regardless of capacity to pay (ie, universality) will continue to be a basic component of living standards in an economically developed society, especially in the context of widening income disparities; and

  • efficiency -- doing what is done at least cost (technical efficiency) and using scarce resources to maximise health outcomes (an aspect of allocative efficiency) -- will become an increasingly important component of health policy.



Equity and efficiency
Despite the theoretical trade-off between equity and efficiency, which applies in certain circumstances, these two objectives are not inconsistent. In fact, a universal national health insurance program gives the government a level of capacity to constrain total health expenditures, which is a necessary (but not sufficient) component of a strategy to increase efficiency. On the other hand, I am convinced that advocacy of improving efficiency by abandoning universal coverage is mistaken, and/or is the product of ideology or self-interest. Consequently, health policy options need to have as their goal the maximisation of efficiency within the framework of the overall equity goal.

"Efficiency" in the economic sense means not only producing at minimum cost, but also managing the system so that it produces, at any given level of cost, that mix of outputs which contributes most to social goals and improved health outcomes. This will inevitably involve changes in industry structure. More complex technology and wider appreciation of the intricate interrelationships between epidemiological and social factors in health will call for an ever-increasing scale and more sophisticated interconnections between various parts of the healthcare sector. These factors impose increasing stresses on present structures for financing and delivering health services in all developed countries.



The Australian scene
In Australia, multiple program and funding streams, overlapping jurisdictions in the federal system of government and poorly articulated relationships between public and private sectors add layers of complexity to the problem. It is a tribute to the funders, managers and providers of health services that our system works as well as it does. On the whole, it provides universal and equitable access to most clinically effective health services, at an overall cost which compares well with those in most comparable countries, and is lower than some. The average citizen requiring health services would be as well treated in the Australian system as anywhere in the world.

In other words, there is no "crisis" which constitutes a case for radical reform in the short term, but rather gradually increasing stresses -- organisational, financial and cultural -- flowing from changing patterns of morbidity and medical care. These stresses are largely or wholly unrelated to universality of access, to the present extent of public/private funding and service provision, or to the overall responsibility of public authorities for regulation of the system.

A rational response to the current situation seems to justify a twofold strategy: first, implement some relatively straightforward measures to deal with specific difficulties, and second, work toward changes in management and funding arrangements to facilitate the evolution of delivery systems to achieve better health and related social outcomes from the available resources (the amount the community is prepared to allocate to these ends).

Many of the options floated in recent years do not meet this specification. To my mind there are only two sensible directions for future reform:

  • Limited reforms designed to ameliorate some systemic problem areas, while maintaining Medicare in more or less its present form; and

  • More substantial reconfiguration of the legal and financial framework of the universal program in the direction of managed competition as a means of promoting increased efficiency of purchasing and service delivery.

These options are not mutually exclusive. Rather, the first might stand alone, or could constitute a preliminary stage towards implementing the second. In fact, if one intended to move to managed care, solving some of the systemic problem areas would be a logical first step.



The short term -- limited reforms
There are several useful reforms which could be undertaken without amending the basic structure of Medicare. The most obvious and important deficiency of the present system relates to access to free hospital treatment, which is currently subject to widespread and lengthy waiting periods. This is largely due to the unsatisfactory nature of the financial arrangements, in which Commonwealth Government funding has never been tied to performance. The original Medibank cost-sharing arrangements allowed only limited control of total costs, and the subsequent method of block grants to the States, which have been in operation since 1981, have enabled some State governments to reduce their level of hospital funding to the point at which access to services has been significantly affected.

This situation could be justified when there was no workable measure of hospital output, but since the development of casemix funding and the Australian national diagnosis-related groups (AN-DRGs) in the early 1990s this excuse no longer holds. The performance of the public hospital system, and the incentives for State governments to treat patients, could be greatly enhanced by replacing most or all Commonwealth Medicare grants to the States by DRG-adjusted case payments direct to hospitals. These payments could be calculated as a percentage of the cost per DRG episode, up to a volume of services determined by the Commonwealth Government.

This payment system would have many benefits beyond the demonstrated increase in efficiency within hospitals. In particular, it would provide a basis for including hospital costs in the pooling of funds for coordinated care arrangements. It would also inhibit (but not eliminate) cost-shifting, and would facilitate detection of abuses, such as the partial diversion of public inpatients to private status. In the longer term, the substitution of case payments for Commonwealth grants would extend the options for more substantial structural reform of the universal program. The implementation of such payments lies well within the readily available powers of the Commonwealth Government.

Other serious deficiencies of the present arrangements have been graphically described by a former State health administrator.1 They include the fragmentation of programs, poor articulation between public and private sector arrangements, and lack of comprehensive data on service utilisation at the individual patient level. The consequences include incapacity to control overservicing, receipt of benefits by ineligible persons, and barriers to developing coordinated care. The causes are partly the jurisdictional overlaps between Commonwealth and States, partly restrictions imposed by privacy legislation and its interpretation, and partly a general paralysis in policy development.

A determined Commonwealth Government might be able to achieve a good deal in all the above respects within the framework of a totally public program, but there would be widespread reservation about the extent to which the Australian people would wish to concede to a government authority, however benign, the implied degree of control over their service use. The British National Health Service, whatever its virtues, is not a model for Australia in the 21st century. Perhaps, more importantly, a monolithic public program would lack incentives to increased allocative efficiency.

In my view, increasing the efficiency with which scarce resources are used to produce health services is the most important determinant of our capacity to provide universal access to state-of-the-art healthcare in the long term. The standard means of achieving this is to increase the exposure of the participants to market incentives. For these reasons, I have become convinced that the best long-term option for Australia would be a system of managed competition.



The longer term -- managed competition?
In a managed competition system, private organisations would be free to compete with public provider(s) in the provision of services covered by public benefit programs such as Medicare, free public hospital care, pharmaceutical benefits, nursing home benefits and so on. The idea is a simple one. However, the formulation of a model in which a private market in healthcare would maximise efficiency in producing good health outcomes, free of risk shifting and other types of gaming, has been a more complex exercise.

It has been said that there are lots of simple answers to complex questions, and that they are all wrong. All health systems are complex, and the Australian system, in several respects, is more complex than most. Any realistic solution is bound also to be complex, and, in the present context, it is possible to offer only the baldest outline of the managed competition model which I have developed progressively over the past decade (Box).2,3

In conclusion, the point has to be made that the rise in real costs of state-of-the-art healthcare will make it increasingly necessary to limit total expenditures on health. Raising the efficiency of resources used to produce services is the only way to minimise the consequent stresses. The managed competition model offers a framework within which higher efficiency can be pursued without sacrificing the principle of universal access, which remains as much as ever a core component of a humane society.


References
  1. Paterson J. National healthcare reform: the last picture show. Melbourne: Department of Human Services (Victoria), 1996.
  2. Scotton R. Managed competition. In: Mooney G, Scotton R, editors. Economics and Australian health policy. Sydney: Allen & Unwin, 1998: 214-231.
  3. Scotton R. Managed competition: the policy context. Aust Health Rev 1999; 22(9): 103-121.



Authors' details
Richard Scotton is a health economist. He and John Deeble, as Research Fellows at the Institute of Applied Economic Research, University of Melbourne, between 1965 and 1970, formulated the program that became Medibank. From 1972 to 1979, Scotton was centrally involved in implementing Medibank, as Special Adviser to Minister for Social Security Bill Hayden and first Chairman of the Health Insurance Commission. Later appointments were Director (Planning) and Commissioner, Health Commission of Victoria; member of the Medicare Planning Committee appointed by Minister for Health Neal Blewett; General Manager (Policy and Planning), Victorian Accident Compensation Commission; and board member, Australian Institute of Health.

Health Economics Unit, Centre for Health Program Evaluation, Monash University, Melbourne, VIC.
Richard B Scotton, AO, BA, BEc, PhD, Honorary Professorial Fellow

©MJA 2000
Make a comment

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  


Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".

<URL: http://www.mja.com.au/> © 2000 Medical Journal of Australia.
We appreciate your comments.


Essential features of a managed competition model2,3

  • All current publicly supported programs - Medicare, free public hospital care, pharmaceutical/nursing home benefits, etc - to be rolled into one, so that all services and benefits for each individual would be paid from the same budget, thus eliminating much cost shifting and encouraging efficient service use.

  • Defined roles for Commonwealth and State governments: the Commonwealth responsibilities limited to financing and the legislative/regulatory framework, and the States to public service provision and overseeing public budget holders.

  • Organisation and management of health service delivery deputed to organisations entitled budget holders, which would be paid (by the Commonwealth Government) a risk-rated capitation for each person enrolled with them, and which would be required to meet all program costs incurred by their enrollees. Risk rating at the individual level is essential to minimise "cream skimming" and other forms of risk selection by budget holders.

  • All persons not opting to be covered by a private budget holder would be covered automatically by a regional budget holder or, as a last resort, by the Health Insurance Commission. Private budget holders would be required to cover all services included in the public program, plus a minimum private hospital entitlement. They would be free to provide wider entitlements to private care, at unsubsidised additional cost.

  • All providers (public and private) would depend for their incomes on payments from budget holders, under contracts or other arrangements (ie, there would be no government benefits or subsidies payable directly to service providers). It could be expected that basic tables (ie, those offering a minimum package of services) would involve some exposure to managed care (ie, medically directed restriction of choice) as incentives to efficient resource use become effective. Another outcome would be that services would be increasingly geared to the needs of people with greater health problems, since they would carry larger capitations. Over time, managed competition could be expected to result in profound structural changes in service provision.
Back to text